{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:39:35Z","timestamp":1791214775155,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4232,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1111\/j.0022-202x.2004.22528.x","type":"journal-article","created":{"date-parts":[[2004,5,7]],"date-time":"2004-05-07T14:19:11Z","timestamp":1083939551000},"page":"1266-1276","source":"Crossref","is-referenced-by-count":117,"title":["Death Receptor-Independent Apoptosis in Malignant Melanoma Induced by the Small-Molecule Immune Response Modifier Imiquimod"],"prefix":"10.1016","volume":"122","author":[{"given":"Michael P.","family":"Sch\u00f6n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Gregor","family":"Wienrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Drewniok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Bong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph C.","family":"Geilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Gollnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2000.tb05598.x","article-title":"The complexity of TNF-related apoptosis-inducing ligand","volume":"926","author":"Abe","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0015","doi-asserted-by":"crossref","first-page":"28505","DOI":"10.1074\/jbc.274.40.28505","article-title":"Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases","volume":"274","author":"Ariza","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0020","first-page":"219","article-title":"Cutaneous melanoma","volume":"19","author":"Armstrong","year":"1994","journal-title":"Cancer Surveys"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0025","doi-asserted-by":"crossref","first-page":"11694","DOI":"10.1074\/jbc.272.18.11694","article-title":"Cleavage of PITSLRE kinases by ICE\/CASP-1 and CPP32\/CASP-3 during apoptosis induced by tumor necrosis factor","volume":"272","author":"Bayaert","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0030","first-page":"2902","article-title":"Cell-mediated cytotoxicity for bladder carcinoma: Evaluation of a workshop","volume":"35","author":"Bean","year":"1975","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2230.2000.00690.x","article-title":"Classical chemotherapy for metastatic melanoma","volume":"25","author":"Becker","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000063904","article-title":"Imiquimod, a novel immune response modifier, in the treatment of cutaneous metastases of malignant melanoma","volume":"205","author":"Bong","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0045","first-page":"121","article-title":"Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma","volume":"10","author":"Bruggen","year":"1981","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/clim.1999.4804","article-title":"The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans cells","volume":"94","author":"Burns","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0055","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The national cancer database report of cutaneous and noncutaneous melanoma","volume":"78","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0060","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1101\/gad.12.11.1551","article-title":"Proteases to die for","volume":"12","author":"Cryns","year":"1999","journal-title":"Genes Dev"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0065","first-page":"5817","article-title":"Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-XL or Bcl-2","volume":"61","author":"Dirsch","year":"2001","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0070","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.4049\/jimmunol.166.9.5337","article-title":"The role of NF-\u03baB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of malignant melanoma","volume":"166","author":"Franco","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0075","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","article-title":"In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors","volume":"51","author":"Giard","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0080","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/jir.1995.15.537","article-title":"Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609","volume":"15","author":"Gibson","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0085","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","article-title":"Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells","volume":"161","author":"Griffith","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-642-19022-3_9","article-title":"Human melanoma: Drug resistance","volume":"161","author":"Helmbach","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ijc.2910410412","article-title":"Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen","volume":"41","author":"Holzmann","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1300","article-title":"Apoptosis and melanoma: Molecular mechanisms","volume":"199","author":"Hussein","year":"2003","journal-title":"J Pathol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0110","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1523-1747.1998.00174.x","article-title":"Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463","volume":"110","author":"Imbertson","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","article-title":"Induction of apoptosis by cancer chemotherapy","volume":"256","author":"Kaufmann","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0120","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/MCB.15.4.2207","article-title":"Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by sendai virus utilize similar signal transduction pathways","volume":"15","author":"Megyeri","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0125","first-page":"148","article-title":"Cytokine induction by imiquimod, preclinical results and pharmacology","volume":"4","author":"Miller","year":"1994","journal-title":"Chemother J"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0130","first-page":"1799","article-title":"Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo","volume":"9","author":"Miyashita","year":"1994","journal-title":"Oncogene"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct trascriptional activator of the human bax gene","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s004030000158","article-title":"Bcl-2 transfected HaCaT keratinocytes resist apoptotic signals of ceramides, tumor necrosis factor alpha, and 1-alpha, 25-dihydroxyvitamin D(3)","volume":"292","author":"M\u00fcller-Wieprecht","year":"2000","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-4608(98)00122-8","article-title":"Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma","volume":"108","author":"Nelson","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.0022-202x.2001.01409.x","article-title":"The bax\/bcl-2 ratio determines the susceptibility of human melanoma cells to CD95\/Fas-mediated apoptosis","volume":"117","author":"Raisova","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jlb.55.2.234","article-title":"Cytokine induction in mice by the immunomodulator imiquimod","volume":"55","author":"Reiter","year":"1994","journal-title":"J Leukocyte Biol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/sj.bjc.6600476","article-title":"The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro","volume":"87","author":"Riebeling","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0165","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bjc.1996.569","article-title":"A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily","volume":"74","author":"Savage","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2230.2000.00694.x","article-title":"Management of malignant melanoma: New developments in immune and gene therapy","volume":"25","author":"Schneeberger","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0175","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"Sch\u00f6n","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0180","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.leu.2401865","article-title":"Death and decoy receptors and p53-mediated apoptosis","volume":"14","author":"Sheikh","year":"2000","journal-title":"Leukemia"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0185","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0002-9440(10)65434-X","article-title":"Alterations of Fas (Apo-1\/CD95) gene in cutaneous malignant melanoma","volume":"154","author":"Shin","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/322007","article-title":"Application of a topically-applied immune response modifier, resiquimod gel, to modify the recurrence rate of genital herpes: A pilot study","volume":"184","author":"Spruance","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0195","first-page":"555","article-title":"Topical imiquimod treatment of a cutaneous melanoma metastasis","volume":"43","author":"Steinmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1523-1747.2000.00833.x","article-title":"Imiquimod, a topical immune response modifier, induces migration of Langerhans cells","volume":"114","author":"Suzuki","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0205","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.7878464","article-title":"Apoptosis in the pathogenesis and treatment of disease","volume":"267","author":"Thompson","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0166-3542(95)00054-P","article-title":"Immunomodulating and antiviral activities of the imidazoquinoline S-28463","volume":"28","author":"Tomai","year":"1995","journal-title":"Antiviral Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2133.2002.488811.x","article-title":"Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread","volume":"147","author":"Ugurel","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0220","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1523-1747.2002.01854.x","article-title":"Regulation of Fas-mediated apoptosis by N-ras in melanoma","volume":"119","author":"Urquhart","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/cimm.1998.1406","article-title":"Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod","volume":"191","author":"Wagner","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0230","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1006\/cyto.1997.0239","article-title":"Induction of cytokines in Cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463","volume":"9","author":"Wagner","year":"1997","journal-title":"Cytokine"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jir.1994.14.81","article-title":"Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro","volume":"14","author":"Weeks","year":"1994","journal-title":"J Interferon Res"},{"key":"10.1111\/j.0022-202X.2004.22528.x_bb0240","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.164.8.3961","article-title":"Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells","volume":"164","author":"Zhang","year":"2000","journal-title":"J Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15308228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15308228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T15:50:23Z","timestamp":1682697023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15308228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022202X15308228"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2004.22528.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}